Investor Relations

The investor pages that follow are your resource for financial information about SenoRx Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Releases

Aug 11, 2008
SenoRx Reports 37.7 Percent Growth in Second Quarter 2008 Revenue; Gross Margins Increase to 61.3 Percent From 57.0 Percent a Year Ago

Jul 29, 2008
SenoRx to Present At the 28th Annual Canaccord Adams Global Growth Conference

more »

Investor Relations Contact:
Lila Churney
949-362-4800 ext 132
lchurney@senorx.com


Stock Information
SENO - (NASD)
$6.04   - 0.04
Aug 20, 2008
4:00 PM ET


Shareholder Tools

Quotes delayed at least 20 minutes.
Information provided by TurboFeed.

 
Home | Physician Information | Patient Information | About SenoRx | Products | Privacy Statement | Contact Us
© Copyright 2008 SenoRx, Inc.